Hartford HealthCare Earns Modern Healthcare’s Innovators Award
HARTFORD, Conn., April 15, 2025 /PRNewswire/ -- Hartford HealthCare (HHC) is honored to announce that it has been awarded Modern...
Cancer
Agamon Health Accelerates Expansion into Community Cancer Market
Announces partnerships with several OnCare Alliance Members to automate chart prep and patient navigation. WILMINGTON, Del., April 15, 2025 /PRNewswire/...
Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation
Collaboration accelerates insights on clinical benefits of molecular profiling across all major categories of disease SAN DIEGO and CHICAGO, April...
CARTI Cancer Center Deploys DeepScribe’s Ambient Operating System for Oncology
The Arkansas-based not-for-profit now uses DeepScribe's oncology-specific AI to document and deliver insights for patients SAN FRANCISCO, April 15, 2025 /PRNewswire/...
Keystone Symposia to Convene Global Leaders in Vaccinology Amidst Rising Public Health Concerns
WASHINGTON, April 15, 2025 /PRNewswire/ -- June 4-7, 2025 – Keystone Symposia will host a timely meeting, "Vaccinology: Horizons Across Disease,...
Optellum Announces Agreement with Bristol Myers Squibb to Leverage AI to Boost Early Lung Cancer Diagnosis
Rapidly growing lung health company aims to redefine early diagnosis and precision lung cancer care using multi-modal artificial intelligence (AI)....
Leap Therapeutics to Host Virtual KOL Event to Discuss Sirexatamab (DKN-01) in Second-line Patients with Advanced Microsatellite Stable Colorectal Cancer
Virtual KOL Event on Wednesday, April 23, 2025, at 2:30 p.m. ET CAMBRIDGE, Mass., April 15, 2025 /PRNewswire/ -- Leap Therapeutics,...
Ezra Appoints Dr. Danna Chung as Chief Medical Officer
Dr. Chung brings expertise in scaling medical teams to Ezra’s mission of making early cancer detection accessible to everyone Dr....
Lyell Immunopharma Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for LYL314 for the Treatment of Relapsed and/or Refractory Large B-Cell Lymphoma
RMAT designation was granted based on promising clinical data from the ongoing Phase 1/2 trial of LYL314 in patients with...
Parexel appoints Charlotte Moser, MD, PhD, MBA as Chief Medical Officer
Veteran Oncologist and Clinical Development expert to lead global medical strategy supporting patient-focused drug development and deliveryDURHAM, N.C., April 15,...
Open nominations for the BIAL Award in Biomedicine 2025 with an increased amount to €350,000
Created to distinguish the most remarkable scientific discoveries in the biomedical field, this international award has been granted a growing reputation...
ACR Statement on JAMA CT Scan Radiation Study (Smith-Bindman, et al)
RESTON, Va., April 14, 2025 /PRNewswire/ -- The theoretical radiation risk proposed by Smith-Bindman, et al, is consistent with prior...
Baird Medical Presents Advanced MWA Technology to UCLA Expert in China
NEW YORK, April 14, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company") recently hosted...
Viome Launches AI-Powered Full Body Intelligence™ Test To Help You Stay Healthy, Slow Aging, and Make Illness Optional
Viome's Full Body Intelligence Test™ is the only science backed at-home test that decodes your body's biological signals to give...
Promino Nutritional Sciences Inc. Launches Second Preclinical Study Targeting Reduction of Muscle Loss in Breast and Prostate Cancer Patients Undergoing Chemotherapy
Research to explore Promino's patented amino acid blend in addressing treatment-related muscle wasting in two of the most prevalent cancers...
Free Oral Cancer Screenings in Honor of Oral, Head and Neck Cancer Awareness Month
26 USOSM Surgeon Partners to Participate Across Seven States IRVING, Texas, April 14, 2025 (GLOBE NEWSWIRE) -- In honor of...
VIVUS Announces Enrollment of First Patient in Phase 2 Clinical Trial Assessing Ethanol-Free Carmustine as a Component of High-Dose Chemotherapy Prior to Transplant in Patients with Hodgkin or Non-Hodgkin Lymphoma
— Innovative ethanol-free formulation intended to provide improved safety and advance care for patients undergoing high-dose conditioning therapy prior to...
PRISM BioLab and Elix Join Forces to Accelerate AI-Driven Drug Discovery for Protein-Protein Interaction Targets
Strategic Partnership Aims to Create Novel Drug Discovery Pipeline for Unmet Medical Needs by Combining PPI Control Technology with AI...
STAGO ANNOUNCES “THE IMPORTANCE OF ROUTINE COAGULATION TESTING” EDUCATIONAL WEBINAR
PARSIPPANY, N.J., April 11, 2025 /PRNewswire/ -- Diagnostica Stago, Inc., a global leader in hemostasis and thrombosis diagnostics, is pleased...
Innovative Startups Developing Next-Gen Cancer Treatments and Radiation-Shielding Material Selected Through MassChallenge Accelerator for Space-Based Research
Through the Technology in Space Prize, two startups will receive more than $650,000 in total funding and the ability to...